Developer docs
API playgroundTry for free, no card

Search company profiles

Globus Medical

Full company profile

uuid003ujb2

Namestring
Globus Medical
Legal namestring
Globus Medical, Inc.
Company typeenum
Public
Founded yearint
2003
Descriptiontext

Globus Medical is a publicly traded musculoskeletal medical device company (NYSE: GMED) headquartered in Audubon, Pennsylvania, that designs, manufactures, and sells spinal implants, orthopedic trauma devices, joint reconstruction systems, and neuromodulation products to hospitals and healthcare systems worldwide. The company is built around the Excelsius Technology ecosystem, an integrated robotic and freehand navigation platform that includes ExcelsiusGPS for spinal and cranial robotic guidance, ExcelsiusFlex for flexible robotic applications, ExcelsiusHub as a freehand navigation system, ExcelsiusXR augmented reality headset, and Excelsius3D imaging, complemented by a Power Portfolio of navigated surgical instruments and a regenerative biologics line. Procedure-specific implant franchises include the Modulus family of 3D-printed porous titanium interbodies, the XLIF lateral lumbar interbody fusion platform, Precice magnetically adjustable limb lengthening systems, and the SECURE-C motion-preserving cervical disc.

The business sells primarily through a direct field sales force that targets orthopedic and neurosurgeons supported by the MERC Musculoskeletal Education and Research Center, which provides cadaveric labs, case reviews, and live surgery observations across multiple countries. Revenue is generated principally through hardware sales of implants and instruments to hospitals and healthcare providers under quote-based, multi-year contracts, with a stated strategic shift toward leasing and rental of the ExcelsiusGPS robotic system to convert capital placements into recurring implant and service revenue. The 2023 merger with NuVasive and 2025 acquisition of Nevro extended the portfolio into combined spine, trauma, joint reconstruction, and chronic pain management, and the company operates across approximately 64 countries with FY2025 revenue of $2.939 billion and Q1 2026 revenue growth of 27% year-over-year.

Short descriptiontext

Globus Medical is a publicly traded musculoskeletal implant and enabling-technology company that designs spinal, orthopedic trauma, joint reconstruction, and neuromodulation products around its Excelsius robotic navigation platform, selling through a direct field sales force to hospitals and surgeons across 64 countries.

Operating statusenum
Operating
Ownership categoryenum
Headcount rangeband
1,001–5,000
akta.pro rankint
HeadquartersAudubon, United States
HQ citystring
Audubon
HQ countrystring
United States
HQ regionstring
North America
Markets served

Serves global market

Offices2 records

Each record includes

City, Country, Type, Description, Source

Keyword5 values
spinal implant devices, robotic surgical navigation, orthopedic trauma solutions, musculoskeletal medical devices, regenerative biologics
Industry3 codes
1Surgical Navigation, Robotics & Patient-Matched Instrumentation (Ortho/Spine)
CodeHLAHAEALPrimaryYes
23D-Printed & Patient-Specific Implants (Custom Ortho/Spine/Cranial)
CodeHLAHAEAJPrimaryNo
3Open & Minimally Invasive Surgical Instruments (Handheld, Laparoscopic, MIS)
CodeHLAHADAAPrimaryNo
NAICS code3 codes
  • Electromedical and Electrotherapeutic Apparatus Manufacturing334510
  • Surgical and Medical Instrument Manufacturing339112
  • Surgical Appliance and Supplies Manufacturing339113
SIC code3 codes
  • Surgical & Medical Instruments & Apparatus3841
  • Orthopedic, Prosthetic & Surgical Appliances & Supplies3842
  • Electromedical & Electrotherapeutic Apparatus3845
Product category
Spinal Implants and Musculoskeletal Medical Devices
GTM motion2 records

Each record includes

Type, Description, Source

Revenue model3 records
1Musculoskeletal Implants and Devices
TypeHardware Sales
Description

Core revenue from spinal implants, orthopedic trauma devices, joint reconstruction products, and regenerative biologics sold to hospitals and healthcare providers through direct sales force

globusmedical.com
2Robotic Systems and Enabling Technology
TypeHardware Sales
Description

Revenue from ExcelsiusGPS robotic navigation system sales and service contracts, with strategic shift toward leasing/rental model for recurring revenue

stockstory.org
3Spine Procedures
TypeHardware Sales
Description

Comprehensive spine solutions including interbody spacers, fixation systems, access systems, and biologics for various surgical approaches (TLIF, XLIF, ALIF, ACDF, deformity, tumor/trauma)

globusmedical.com
Marketing channels6 records

Each record includes

Title, Type, Stage, Description, Source

Distribution channels1 record

Each record includes

Title, Type, Scope, Target buyer, Description, Source

Cost components6 values
Operations, Supply Chain, Personnel, Technology or R&D, Marketing or Sales, Infrastructure
Pricing details1 tier
1Quote-based pricing for hospitals and healthcare systems
ModelOtherBilling cadenceMulti-year contract
Notes

Pricing determined through direct sales negotiations with healthcare facilities; no public pricing list available

globusmedical.com
GTM typeB2B
B2B
Offering typeHardware or Manufacturing
Hardware or Manufacturing
Core offering1 text field

Globus Medical designs, manufactures, and sells musculoskeletal medical devices focused on spinal implants, robotic and freehand surgical navigation systems, orthopedic trauma solutions, joint reconstruction systems, and regenerative biologics. The Excelsius™ Technology ecosystem (ExcelsiusGPS™, ExcelsiusFlex™, ExcelsiusHub™, ExcelsiusXR™, Excelsius3D™) serves as the enabling technology platform that integrates with procedurally integrated implant and instrument portfolios. The company sells to hospitals, ambulatory surgery centers, and orthopedic/neurosurgeons globally through direct field sales.

Differentiator
Functional benefit
Problem solved
Quantifiable outcome1 of 7 values shown
  • Third consecutive quarter of 10%+ U.S. Spine growth
+6 more records
Product overview1 text field

Globus Medical is a musculoskeletal solutions company offering a comprehensive portfolio of spinal implants, surgical technologies, and biologics organized around its Excelsius™ Technology ecosystem. The core platform includes ExcelsiusGPS™ (robotic navigation), ExcelsiusFlex™ (flexible robotic navigation), ExcelsiusHub™ (freehand navigation), ExcelsiusXR™ (AR headset), and Excelsius3D™ (imaging) systems. Key product lines include Modulus™ 3D-printed porous titanium implants (Cervical, XLIF, ALIF, TLIF variants), the Precice™ magnetically adjustable limb lengthening system, SECURE-C™ cervical disc, XLIF™ lateral fusion technology, and TLIF procedure solutions. Supporting offerings include Regenerative Biologics, Power Portfolio (DuraPro™, Verzera™), SpineTRACK™ and OrthoTRACK™ registries, and the MERC education and research center providing surgeon training and fellowship programs. The company operates with a platform-plus-modules architecture where Excelsius technology serves as the enabling technology platform integrated with various implant and procedure-specific products.

Product and service2 records
1ExcelsiusGPS™
CategoryRobotic Surgical Navigation
Description

Robotic navigation platform for spinal and cranial surgery that provides real-time guidance and visualization to improve surgical precision and patient outcomes for hospitals and surgeons.

2ExcelsiusFlex™
Scale indicator15 records

Each record includes

Type, Value, Description, Source

Recent move7 records

Each record includes

Date, Type, Title, Description, Source

Expansion highlight6 records

Each record includes

Type, Description

Peers10 records
TypeBroad incumbent
Description

Competitor in neuromodulation via the Proclaim XR spinal cord stimulation platform and chronic pain therapy offerings. Comparable end market to Nevro's HFX and broader pain management segment within Globus.

TypeBroad incumbent
Description

Direct competitor in spinal cord stimulation (Precision Spectra, WaveWriter) following the Nevro acquisition. Comparable neuromodulation portfolio and end-market, though Boston Scientific operates a much broader medtech portfolio.

TypeBroad incumbent
Description

Major spine and orthopedics franchise through DePuy Synthes, including the VELYS enabling technology platform. Comparable product overlap in spinal fusion, deformity, and trauma; much larger parent with broader medtech portfolio.

TypeBroad incumbent
Description

Orthopedic reconstruction leader (hip and knee) and increasingly adjacent to enabling technologies. Comparable to Globus's joint reconstruction and trauma portfolios, though much larger and more focused on reconstruction than spine.

TypeBroad incumbent
Description

Largest competitor in spine hardware and surgical robotics via the Mazor X robotic platform. Comparable to Globus in cervical/thoracolumbar implants, navigation, and enabling technologies, but with a much broader diversified medtech portfolio.

TypeDirect peer
Description

Focused on sacroiliac joint fusion and other spine-adjacent musculoskeletal solutions using proprietary triangular titanium implants. Comparable in spine procedural specialization and surgeon training focus, though narrower in scope.

TypeDirect peer
Description

Pure-play spine company with a procedurally integrated portfolio and a focus on lateral and MIS approaches. Closely comparable in scale, product mix, and surgeon-focused GTM motion.

TypeDirect peer
Description

Spine and orthopedic trauma company with biologics, fixation, and pulsed electromagnetic field stimulation. Comparable in musculoskeletal implants and biologics, though smaller scale and weaker in robotic enabling tech.

TypeDirect peer
Description

Smaller pure-play spine company with a portfolio of spinal hardware and digital health (HOLO Portal). Directly comparable in spine implant focus and product mix, though much smaller scale.

TypeBroad incumbent
Description

Operates in spine (post-Wright Medical acquisition) and surgical robotics (Mako). Directly comparable to Globus in spinal procedures and enabling technology but serves multiple end-markets including orthopedics and surgical instruments.

Market position
Strengths5 records

Each record includes

Headline, Details, Source

Weaknesses5 records

Each record includes

Headline, Details, Source

Competitive moat6 records

Each record includes

Type, Details

Key risks6 records

Each record includes

Headline, Details, Source

Key highlights7 records

Each record includes

Headline, Details, Source

Customer concentration

Classification, Details

Named customers3 records

Each record includes

Name, Industry, Type, Use case, Source, UUID

Segment4 records

Each record includes

Title, Type, Primary, Description, Pain point addressed, Use case, Source

Ideal customer profile1 record

Each record includes

Profile, Firmographic size, Sales motion, Sales cycle length, Buying structure, Purchase trigger, Buyer persona, Geography, Industry vertical, Primary use case, Description, Pain points, Evidence proof points, Target buyer

Technology focused
Yes
API detail
Has APIbool
No

Docs URL, Description

Integration2 records

Each record includes

Title, Type, Description, Source

AI maturity
App detail

Has app

Feature9 records

Each record includes

Title, Differentiator, Description, Source

Core technology
Revenue estimate
Valuation estimate
Number of profiles
Profiles10 records

Each record includes

Name, Designation, Designation category, Overview, Profile commentary, Source

Subsidiaries3 records

Each record includes

Name, Acquired on, Relationship type, Type, Business focus

No data
Funding overview

Funding stage, Last funding date, Total funding USD

Funding rounds5 records

Each record includes

Round, Amount USD, Date, Pre money valuation, Total investors, Investors, News

Investors4 records

Each record includes

Name, Type, Date of entry, Rounds participated, Website

Funding detail is available on the Subscription and Enterprise plan.Contact sales →

M&A12 records

Each record includes

Name, Acquisition type, Announced date, Completed date, Status, Website, News

Investment

Each record includes

Name, Round, Announced date, Lead investor, Website, News

M&A and investment is available on the Subscription and Enterprise plan.Contact sales →

Globus Medical

Spinal Implants and Musculoskeletal Medical Devicesglobusmedical.com

Globus Medical is a publicly traded musculoskeletal implant and enabling-technology company that designs spinal, orthopedic trauma, joint reconstruction, and neuromodulation products around its Excelsius robotic navigation platform, selling through a direct field sales force to hospitals and surgeons across 64 countries.

What Globus Medical does

Globus Medical is a publicly traded musculoskeletal medical device company (NYSE: GMED) headquartered in Audubon, Pennsylvania, that designs, manufactures, and sells spinal implants, orthopedic trauma devices, joint reconstruction systems, and neuromodulation products to hospitals and healthcare systems worldwide. The company is built around the Excelsius Technology ecosystem, an integrated robotic and freehand navigation platform that includes ExcelsiusGPS for spinal and cranial robotic guidance, ExcelsiusFlex for flexible robotic applications, ExcelsiusHub as a freehand navigation system, ExcelsiusXR augmented reality headset, and Excelsius3D imaging, complemented by a Power Portfolio of navigated surgical instruments and a regenerative biologics line. Procedure-specific implant franchises include the Modulus family of 3D-printed porous titanium interbodies, the XLIF lateral lumbar interbody fusion platform, Precice magnetically adjustable limb lengthening systems, and the SECURE-C motion-preserving cervical disc.

The business sells primarily through a direct field sales force that targets orthopedic and neurosurgeons supported by the MERC Musculoskeletal Education and Research Center, which provides cadaveric labs, case reviews, and live surgery observations across multiple countries. Revenue is generated principally through hardware sales of implants and instruments to hospitals and healthcare providers under quote-based, multi-year contracts, with a stated strategic shift toward leasing and rental of the ExcelsiusGPS robotic system to convert capital placements into recurring implant and service revenue. The 2023 merger with NuVasive and 2025 acquisition of Nevro extended the portfolio into combined spine, trauma, joint reconstruction, and chronic pain management, and the company operates across approximately 64 countries with FY2025 revenue of $2.939 billion and Q1 2026 revenue growth of 27% year-over-year.

Globus Medical firmographics

Firmographics
Name
Globus Medical
Legal name
Globus Medical, Inc.
Website
https://globusmedical.com
Company type
Public
Founded year
2003
Operating status
Operating
Headcount range
1,001–5,000 employees
Short description
Globus Medical is a publicly traded musculoskeletal implant and enabling-technology company that designs spinal, orthopedic trauma, joint reconstruction, and neuromodulation products around its Excelsius robotic navigation platform, selling through a direct field sales force to hospitals and surgeons across 64 countries.
Ownership category
akta.pro rank

Globus Medical industry classification

Industry
Product category
Spinal Implants and Musculoskeletal Medical Devices
NAICS
Electromedical and Electrotherapeutic Apparatus Manufacturing (334510), Surgical and Medical Instrument Manufacturing (339112), Surgical Appliance and Supplies Manufacturing (339113)
SIC
Surgical & Medical Instruments & Apparatus (3841), Orthopedic, Prosthetic & Surgical Appliances & Supplies (3842), Electromedical & Electrotherapeutic Apparatus (3845)
akta.pro primary industry
Surgical Navigation, Robotics & Patient-Matched Instrumentation (Ortho/Spine) (HLAHAEAL)
akta.pro secondary industries
3D-Printed & Patient-Specific Implants (Custom Ortho/Spine/Cranial) (HLAHAEAJ), Open & Minimally Invasive Surgical Instruments (Handheld, Laparoscopic, MIS) (HLAHADAA)

Keywords

  • Spinal implant devices
  • Robotic surgical navigation
  • Orthopedic trauma solutions
  • Musculoskeletal medical devices
  • Regenerative biologics

Where Globus Medical is headquartered

Location

Headquarters

HQ city
Audubon
HQ country
United States
HQ region
North America

Offices2 records

Markets served

Globus Medical business model

Business model
GTM type
B2B
Offering type
Hardware or Manufacturing
Cost components
Operations, Supply Chain, Personnel, Technology or R&D, Marketing or Sales, Infrastructure

Revenue model

  1. Musculoskeletal Implants and Devices: Core revenue from spinal implants, orthopedic trauma devices, joint reconstruction products, and regenerative biologics sold to hospitals and healthcare providers through direct sales force
  2. Robotic Systems and Enabling Technology: Revenue from ExcelsiusGPS robotic navigation system sales and service contracts, with strategic shift toward leasing/rental model for recurring revenue
  3. Spine Procedures: Comprehensive spine solutions including interbody spacers, fixation systems, access systems, and biologics for various surgical approaches (TLIF, XLIF, ALIF, ACDF, deformity, tumor/trauma)

Pricing tiers

ModelBillingPrice
OtherMulti-year contractQuote-based pricing for hospitals and healthcare systems

Go-to-market motion2 records

Distribution channels1 record

Marketing channels6 records

Globus Medical product offering

Product offering

Core offering

Globus Medical designs, manufactures, and sells musculoskeletal medical devices focused on spinal implants, robotic and freehand surgical navigation systems, orthopedic trauma solutions, joint reconstruction systems, and regenerative biologics. The Excelsius™ Technology ecosystem (ExcelsiusGPS™, ExcelsiusFlex™, ExcelsiusHub™, ExcelsiusXR™, Excelsius3D™) serves as the enabling technology platform that integrates with procedurally integrated implant and instrument portfolios. The company sells to hospitals, ambulatory surgery centers, and orthopedic/neurosurgeons globally through direct field sales.

Product overview

Globus Medical is a musculoskeletal solutions company offering a comprehensive portfolio of spinal implants, surgical technologies, and biologics organized around its Excelsius™ Technology ecosystem. The core platform includes ExcelsiusGPS™ (robotic navigation), ExcelsiusFlex™ (flexible robotic navigation), ExcelsiusHub™ (freehand navigation), ExcelsiusXR™ (AR headset), and Excelsius3D™ (imaging) systems. Key product lines include Modulus™ 3D-printed porous titanium implants (Cervical, XLIF, ALIF, TLIF variants), the Precice™ magnetically adjustable limb lengthening system, SECURE-C™ cervical disc, XLIF™ lateral fusion technology, and TLIF procedure solutions. Supporting offerings include Regenerative Biologics, Power Portfolio (DuraPro™, Verzera™), SpineTRACK™ and OrthoTRACK™ registries, and the MERC education and research center providing surgeon training and fellowship programs. The company operates with a platform-plus-modules architecture where Excelsius technology serves as the enabling technology platform integrated with various implant and procedure-specific products.

Differentiator

Problem solved

Functional benefit

Products and services

  • ExcelsiusGPS™ Robotic navigation platform for spinal and cranial surgery that provides real-time guidance and visualization to improve surgical precision and patient outcomes for hospitals and surgeons.
  • ExcelsiusFlex™

Quantifiable outcome

  • Third consecutive quarter of 10%+ U.S. Spine growth
  • +6 more outcomes

Companies that use Globus Medical

Customer profile

Named customers3 records

Segments4 records

Ideal customer profiles1 record

Globus Medical technology and API

Technology

Technology focussed Yes

API detail

Has API
No
API docs
API detail

Core technology

AI maturity

App detail

Integration2 records

Feature9 records

Globus Medical partnerships and signals

Strategic signal

Scale indicators15 records

Recent moves7 records

Expansion highlights6 records

Globus Medical competitors and assessment

Company assessment

Broad incumbents

  • Abbott: Competitor in neuromodulation via the Proclaim XR spinal cord stimulation platform and chronic pain therapy offerings. Comparable end market to Nevro's HFX and broader pain management segment within Globus.
  • Boston Scientific: Direct competitor in spinal cord stimulation (Precision Spectra, WaveWriter) following the Nevro acquisition. Comparable neuromodulation portfolio and end-market, though Boston Scientific operates a much broader medtech portfolio.
  • Johnson & Johnson (DePuy Synthes): Major spine and orthopedics franchise through DePuy Synthes, including the VELYS enabling technology platform. Comparable product overlap in spinal fusion, deformity, and trauma; much larger parent with broader medtech portfolio.
  • Zimmer Biomet: Orthopedic reconstruction leader (hip and knee) and increasingly adjacent to enabling technologies. Comparable to Globus's joint reconstruction and trauma portfolios, though much larger and more focused on reconstruction than spine.
  • Medtronic: Largest competitor in spine hardware and surgical robotics via the Mazor X robotic platform. Comparable to Globus in cervical/thoracolumbar implants, navigation, and enabling technologies, but with a much broader diversified medtech portfolio.
  • Stryker: Operates in spine (post-Wright Medical acquisition) and surgical robotics (Mako). Directly comparable to Globus in spinal procedures and enabling technology but serves multiple end-markets including orthopedics and surgical instruments.

Direct peers

  • SI-BONE: Focused on sacroiliac joint fusion and other spine-adjacent musculoskeletal solutions using proprietary triangular titanium implants. Comparable in spine procedural specialization and surgeon training focus, though narrower in scope.
  • Alphatec Holdings (ATEC): Pure-play spine company with a procedurally integrated portfolio and a focus on lateral and MIS approaches. Closely comparable in scale, product mix, and surgeon-focused GTM motion.
  • Orthofix Medical: Spine and orthopedic trauma company with biologics, fixation, and pulsed electromagnetic field stimulation. Comparable in musculoskeletal implants and biologics, though smaller scale and weaker in robotic enabling tech.
  • Surgalign Holdings: Smaller pure-play spine company with a portfolio of spinal hardware and digital health (HOLO Portal). Directly comparable in spine implant focus and product mix, though much smaller scale.

Market position

Strengths5 records

Weaknesses5 records

Competitive moat6 records

Key risks6 records

Key highlights7 records

Customer concentration

Globus Medical social profiles

Digital presence

Globus Medical financial estimates

Financial estimate

Revenue estimate

Valuation estimate

Globus Medical leadership team

Management profile

Number of profiles

Profiles10 records

Globus Medical subsidiaries and ownership

Company hierarchy

Subsidiaries3 records

Globus Medical funding detail

Funding detail

Funding overview

Funding rounds5 records

Investors4 records

Funding detail is available on the Subscription and Enterprise plan.Contact sales →

Globus Medical M&A and investment

M&A and investment

M&A12 records

Investments

M&A and investment is available on the Subscription and Enterprise plan.Contact sales →

Frequently asked questions about Globus Medical

What does Globus Medical do?

Globus Medical designs, manufactures, and sells musculoskeletal medical devices focused on spinal implants, robotic and freehand surgical navigation systems, orthopedic trauma solutions, joint reconstruction systems, and regenerative biologics. The Excelsius™ Technology ecosystem (ExcelsiusGPS™, ExcelsiusFlex™, ExcelsiusHub™, ExcelsiusXR™, Excelsius3D™) serves as the enabling technology platform that integrates with procedurally integrated implant and instrument portfolios. The company sells to hospitals, ambulatory surgery centers, and orthopedic/neurosurgeons globally through direct field sales.

Is Globus Medical a public or private company?

Globus Medical is a public company. It is classified as public and is currently operating.

When was Globus Medical founded?

Globus Medical was founded in 2003. It employs 1,001 to 5,000 people.

Where is Globus Medical based?

Globus Medical is headquartered in Audubon, United States, in the North America region.

How does Globus Medical make money?

Three revenue lines are on record. Musculoskeletal Implants and Devices are the primary driver. The others are robotic Systems and Enabling Technology and spine Procedures.

Who are Globus Medical's main competitors?

Broad incumbents on record are Abbott, Boston Scientific, Johnson & Johnson (DePuy Synthes), Zimmer Biomet, Medtronic and Stryker. Direct peers are SI-BONE, Alphatec Holdings (ATEC), Orthofix Medical and Surgalign Holdings.

Does Globus Medical have an API?

No public API is recorded for Globus Medical.

What industry is Globus Medical in?

Globus Medical's product category is Spinal Implants and Musculoskeletal Medical Devices. Its primary akta.pro industry code is HLAHAEAL, Surgical Navigation, Robotics & Patient-Matched Instrumentation (Ortho/Spine), with a secondary code of HLAHAEAJ, 3D-Printed & Patient-Specific Implants (Custom Ortho/Spine/Cranial). Its NAICS code is 334510 and its SIC code is 3841.

Unlock the full company data

50 free credits on sign-up, no credit card required.

Contact sales
Live signals
Defense WorldGlobus Medical, Inc. $GMED Shares Acquired by Congress Asset Management Co.Congress Asset Management Co. increased its stake in Globus Medical by 6.6% in Q3, holding 361,026 shares worth $27 million. Globus Medical reported Q2 EPS of $1.34, beating estimates, with revenue up 5.9% year-over-year. The company set FY2026 guidance of $4.95-$5.05 EPS.ChartmillGlobus Medical (NYSE:GMED): A Quality Investing Case Built on Durable GrowthGlobus Medical meets the Caviar Cruise quality-growth screen with 8.25% revenue growth, 36% EBIT growth, and 25.7% ROIC. The company shows strong profitability and low debt, but forward growth is expected to slow. The stock trades at a valuation below industry and S&P 500 averages.Markets DailyComparing Lifeward (NASDAQ:LFWD) and Globus Medical (NYSE:GMED)Lifeward and Globus Medical are compared across financial metrics, with Lifeward showing higher upside potential. Globus Medical has higher revenue and earnings, but Lifeward trades at a lower P/E ratio and has a higher consensus target price. Analysts favor Lifeward due to its higher probable upside.YahooZacks Industry Outlook Globus Medical, Intuitive Surgical and Thermo Fisher ScientificZacks Equity as Globus Medical, Intuitive Surgical, and Thermo Fisher Scientific, citing GenAI adoption and M&A trends. The industry's Zacks Industry Rank is #86, and consensus estimates call for 25.4% EPS growth for all three in 2026.American Banking and Market NewsGlobus Medical (NYSE:GMED) versus Lifeward (NASDAQ:LFWD) Critical SurveyLifeward and Globus Medical are compared on financial metrics, with Globus Medical showing higher revenue and earnings but Lifeward having a lower price-to-earnings ratio. Analysts rate Globus Medical higher, but Lifeward has a higher consensus target price, implying greater upside.Ticker ReportComparing CONMED (NYSE:CNMD) & Globus Medical (NYSE:GMED)Globus Medical and CONMED are compared on valuation, earnings, and analyst ratings. Globus Medical has higher revenue ($2.94B vs $1.37B) and earnings, and a lower P/E ratio, with a consensus price target of $99.46 implying 31.52% upside. CONMED's target is $41.40, implying 10.67% downside.Simply Wall StGlobus Medical (GMED), Why Is The Story Getting More Complicated?Globus Medical's stock closed at $75.60, trading below its fair value estimate of $103.23. Analysts expect margin expansion from manufacturing efficiencies and M&A synergies, but risks persist from Enabling Technologies revenue volatility and Nevro's profitability reset.PR NewswireTop Los Angeles Spine Surgeon Dr. Albert Wong Served as Faculty Leader at Advanced Spine Surgery Cadaver Training Courses for SeaSpine and GlobusDr. Albert Wong, neurosurgeon at DOCS Health, led two cadaver training courses in 2026: a SeaSpine-sponsored course for UC system residents and a Globus-sponsored course for practicing surgeons in San Diego. He taught minimally invasive endoscopic surgery, artificial disc replacement, and prone lateral transpsoas lumbar fusion, with the latter enabling 360-degree deformity correction.YahooQ2 Earnings Highs And Lows: Globus Medical (NYSE:GMED) Vs The Rest Of The Medical Devices & Supplies - Specialty StocksGlobus Medical reported Q2 revenue of $789.6 million, up 5.9% year on year, beating analyst estimates by 0.9%. The stock fell 8.8% after the report. Other peers also reported Q2 results, with Inspire Medical Systems up 32.3% and Enovis down 39.6%.Platum[BLT칼럼] '만능'이라고 쓴 청구항, 만능인 제품만 잡았다 - 플래텀The U.S. Court of Appeals ruled on September 11, 2026, that the preamble of two spinal implant patents limited the scope of rights, requiring the patent holder to prove the defendant's product was 'universal' across spine regions and approaches. The patent holder acknowledged it could not prove infringement under that interpretation, and the ruling was designated as precedent.